Cita APA (7a ed.)

Wang, Z., Liu, C., Bai, Y., Zhao, X., Cui, L., Peng, Z., . . . Shen, L. (2021). Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Wang, Zhenghang, et al. Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Wang, Zhenghang, et al. Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer. Frontiers Media S.A, 2021.